|
Market Cap (6-Jul) $758,238,016 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (19-Jun) 895,750 (0.15%) (396th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 8 June 2021, 9:51. The announcement is marked as price sensitive, and is 6 page(s) in length and 389.99kb in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.003% short sold according to ASIC data. It was ranked the 619th most shorted stock on the ASX. It is now ranked as the 396th most shorted stock on the ASX with 0.154% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| Second Drug Program Progressing Towards Human Trials | 8 June 2021, 9:51 |
| Trading Halt | 7 June 2021, 9:31 |
| Evercore ISI GenomeRx Emerging Therapeutic Company Day | 26 May 2021, 8:22 |
| SECOND DRUG PROGRAM - EFFICACY DATA IN PATIENT CELL MODELS | 18 May 2021, 8:23 |
You must be logged in to post a reply.
